Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Diagnostics & Research

Metropolis Healthcare Limited provides diagnostic services in India and internationally. The company offers clinical laboratory testing, and profiles services. It also provides diagnostic services for oncology, neurology, gynecology, and nephrology, as well as various health check-up packages for men, women, senior citizens, and youth and corporates. Its tests and profiles are used for prediction, early detection, diagnostic screening, and confirmation and/or monitoring of the disease. In addition, the company offers corporate wellness, laboratory in, and clinical research services. Metropolis Healthcare Limited was founded in 1981 and is headquartered in Mumbai, India.

Revenue projections:

Revenue projections for METROPOLIS
Revenue projections for METROPOLIS

METROPOLIS's revenue projections indicate a decrease from the prior year, which may make investors hesitant. A revenue decline could harm the company's bottom line, prompting investors to be more careful, as lower earnings often signal potential issues with profitability and future performance.

Financial Ratios:

currentRatio 0.000000
forwardPE 39.747753
debtToEquity 15.956000
earningsGrowth 0.153000
revenueGrowth 0.109000
grossMargins 0.778610
operatingMargins 0.137290
trailingEps 29.550000
forwardEps 0.000000

Metropolis Healthcare Limited's low Debt-to-Equity ratio shows the company avoids heavy reliance on debt. This balanced approach reduces financial risk, as it maintains a healthy equity position without excessive leverage, providing greater financial stability and flexibility.
Metropolis Healthcare Limited's positive earnings and revenue growth indicate that the company is well-positioned for business expansion. This growth suggests a strong financial trajectory, with Metropolis Healthcare Limited expected to continue increasing its profits and revenue in the coming periods.

Price projections:

Price projections for METROPOLIS
Price projections for METROPOLIS

The gradual downward revision of METROPOLIS's price projections signals decreasing confidence in the company's future performance. Analysts are adjusting their expectations, reflecting uncertainty about METROPOLIS's growth potential.

Insider Transactions:

Insider Transactions for METROPOLIS
Insider Transactions for METROPOLIS


2 transactions were made to sell METROPOLIS shares, with market price of 2095.9249267578125.During the review period, no sell transactions were executed.The trend of more buys than sells at METROPOLIS's current price levels suggests a possible bullish sentiment. This could indicate that investors are expecting a favorable outlook for the stock, prompting more buying activity.

Recommendation changes over time:

Recommendations trend for METROPOLIS
Recommendations trend for METROPOLIS


METROPOLIS has recently received a buy bias from analysts, indicating that the stock is being perceived as a favorable investment. This positive sentiment could encourage investors to see METROPOLIS as a wise place to allocate their funds, potentially leading to increased interest in the company's stock.